跳至主要内容
临床试验/NCT05867537
NCT05867537进行中(未招募)不适用

Proof of Concept Human Study: Dietary Intervention to Modify Intestinal Inflammation in IBD

Universitätsklinikum Hamburg-Eppendorf2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2023年1月18日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
20
试验地点
2
主要终点
Change in clinical and endoscopic parameters of intestinal inflammation following 78 weeks of long-term gluten free dietary intervention, compared to pre-interventional levels in ulcerative colitis (UC) and PSC-IBD

研究概览

简要总结

The objective of this clinical study is to demonstrate efficacy and feasibility of a long-term dietary intervention to modify intestinal inflammation in high-risk patient cohorts. To this end a 78 weeks wheat protein-free diet will be administered in patients with inflammatory bowel disease (IBD) with and without associated primary sclerosing cholangitis (PSC-IBD).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Confirmed diagnosis of UC, CD or PSC-IBD
  • Willingness, to follow a gluten-free diet for 78 weeks
  • Stable therapeutic treatment for more 8 weeks
  • For CD: Harvey Bradshaw index (HBI) of more 5 points, corresponding to a minimum of mild intestinal inflammation in CD
  • For UC: Mayo Score of more 2 points, corresponding to a minimum of mild intestinal inflammation in UC
  • Patient signed informed consent

排除标准

  • Antibiotics during last 4 weeks
  • Intake of probiotics
  • Gluten-free diet is already practiced
  • Concomitant diagnosis of celiac disease
  • Positive serology for transglutaminase IgA / IgG antibody or deamidated gliadin IgA / IgG
  • Breast feeding
  • Pregnancy

结局指标

主要结局

Change in clinical and endoscopic parameters of intestinal inflammation following 78 weeks of long-term gluten free dietary intervention, compared to pre-interventional levels in ulcerative colitis (UC) and PSC-IBD

时间窗: 78 Weeks + 12 Month follow-up

Change of partial Mayo Score (pMS) for UC and PSC-IBD following 78 weeks of long-term gluten free dietary intervention. pMS range from 0 to 12 points (remission: pMS \< 2, mild activity: pMS 2-4, moderate activity: pMS 5-7, severe activity: pMS \> 7).

Change in clinical and endoscopic parameters of intestinal inflammation following 78 weeks of long-term gluten free dietary intervention, compared to pre-interventional levels in crohn´s disease (CD)

时间窗: 78 Weeks + 12 Month follow-up

Change of Harvey bradshaw index (HBI) for CD following 78 weeks of long-term gluten free dietary intervention. HBI range from 0 to 18 points + number of daily liquid stools (remission: HBI \< 5, active disease: HBI ≥ 5, severe disease: HBI ≥ 8)

次要结局

  • The efficacy and feasibility of a long-term dietary intervention to change mucosal transcripts of IL-6 of the intestine in IBD patients(78 Weeks + 12 Month follow-up)
  • Long-term dietary influence on intestinal microbiome in IBD patient cohorts(78 Weeks + 12 Month follow-up)
  • The efficacy and feasibility of a long-term dietary intervention to change mucosal transcripts of TNF-alpha of the intestine in IBD patients(78 Weeks + 12 Month follow-up)
  • The efficacy and feasibility of a long-term dietary intervention to change mucosal transcripts of IL-10 of the intestine in IBD patients(78 Weeks + 12 Month follow-up)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Samuel Huber

Director of the I. Department of Medicine, Prof. Dr. med.

Universitätsklinikum Hamburg-Eppendorf

研究点 (2)

Loading locations...

相似试验